
Homeland Peptides /Peptides / Tirzepatide
Tirzepatide
1 mg weekly to start
Studied for
- Stronger fat loss
- Quiets hunger
- Fewer cravings
Tirzepatide is a dual GIP and GLP-1 agonist studied for weight and glucose research. The reference start is 1 mg once weekly, titrated by 0.25 mg weekly to the BMI maintenance level. Once that dose is reached, it is kept every week. Coming off means dropping 0.25 mg each week back to 1 mg, then stopping.
Ships from the United States. Delivery within 5-7 business days. Discreet shipping. Tested to a 98% purity floor.
- Also called
- GIP and GLP-1
- Form
- Lyophilized powder
- Tested
- 98%+ on an independent lab.